Drug Profile
Hepatitis C DNA vaccine - ChronTech
Alternative Names: ChronVac-C; NS3/4a DNA vaccineLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Tripep
- Developer ChronTech Pharma
- Class Antivirals; DNA vaccines; Hepatitis C vaccines
- Mechanism of Action Gene transference; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Hepatitis-C(Combination therapy) in Sweden (IM, Injection)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Hepatitis-C(Monotherapy) in Sweden (IM, Injection)
- 23 Jul 2015 Clinical development is ongoing in Sweden